bioRxivImmunologyPreprint
Cross-sectional association study from NHANES between some dietary supplements and anti-HAV antibodies
Hussein S SalamaiD, Hadeer M. Nageeb, Mostafa Ibrahim AbdelgliliD, Mingxuan Hou, Xi ZhengiD, Yangyang DongiD, Ling Yang
Abstract
Background/Objectivesdietary supplements intake is known for its importance in preserving immune system and immune response but we need to estimate if there were direct cross-sectional association between some dietary supplements use 24-hours and anti-HAV antibodies or not. Methodsdata merged from three NHANES three cycles along (2013-2018) were analyzed, representing 29.400 participants across all ages. The data collected were subjected to a logistic regression analysis to assess the relationship between the reported frequency of infections and dietary nutrients consumed including minerals and some vitamins. Resultsthe results in overall verified no significant association between investigated dietary supplements use 24-hours and anti-HAV antibodies. However, vitamin D (p = 0.004) showed a significant positive association. Conclusionsthere were true direct association revealed of vitamin D on anti-HAV antibodies.
- organism: human
- assay: clinical cohort / trial
- research focus: differential expression
- approach: statistical model
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Neuraminidase-Based Cross-Protective Immunity against H5N1 Influenza Viruses in Humans
Iván Sanz-Muñoz, Carlos J. Ciria-Gil, … Aitor Nogales·bioRxiv·Jun 12, 2026
- Low levels of H5N1 HA and NA antibodies in the human population are boosted by seasonal A/H1N1 infection but not by A/H3N2 infection or influenza vaccination
Anne P. Werner, Cosette G. Schneider, … Andrew S Pekosz·mBioPeer-reviewed·Oct 31, 2025
- In vivo administration of anti-HIV hyper-immune eggs induces anti-anti-idiotypic antibodies against HIV gp120 peptides (fragments 308-331 and 421-438) and against HIV gp41 peptide (fragment 579-601) which have demonstrable protective capacity.
A. A. J. Vaillant, B. Ferrer-Cosme, … O. Perez·bioRxiv·May 2, 2021
- Antigenic mapping and functional characterization of human New World hantavirus neutralizing antibodies
T. B. Engdahl, E. Binshtein, … J. E. Crowe·bioRxiv·Jul 19, 2022
- Acute Hepatitis E Virus infection in two geographical regions of Nigeria
I. M. Ifeorah, T. O. C. Faleye, … J. A. Adeniji·bioRxiv·Aug 20, 2017
- Different vaccine platforms result in distinct antibody responses to the same antigen in haemodialysis patients
N. Wall, R. Lamerton, … A. F. Cunningham·bioRxiv·Jan 14, 2024